Literature DB >> 23240630

Elevated KIAA0101 expression is a marker of recurrence in human gastric cancer.

Kun Zhu1, Dongmei Diao, Chengxue Dang, Lei Shi, Jianguang Wang, Rong Yan, Dawei Yuan, Kang Li.   

Abstract

Gastric cancer (GC) is one of the most common malignant tumors with a high rate of recurrence, which results in surgery being unsuccessful. Therefore, it is important to find the reason for the surgery failing. The purpose of the present study was to investigate a factor related to recurrence. Expression of KIAA0101 was assessed in 61 paired human primary GC and non-cancerous gastric tissue using immunohistochemistry. After surgery, all 61 patients were followed regularly for more than 24 months or until death to analyze the 2-year survival rate and recurrence. After suppressing KIAA0101 by RNA interference in human GC cell lines, the cell viability was detected using MTT. We are first to find that KIAA0101 was elevated in GC tissues compared with paired non-cancerous gastric tissues. Immunohistochemical staining also revealed the predominant nuclear localization of KIAA0101 protein. Despite these findings, GC patients with elevated KIAA0101 expression levels exhibited a high recurrence and subsequently poor prognosis in the survival study. Also, cell viability was significantly inhibited after suppressing KIAA0101 in GC cells, suggesting that KIAA0101 might promote cancer cell proliferation. KIAA0101 is increased in human GC and is a marker of recurrence.
© 2012 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23240630     DOI: 10.1111/cas.12083

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  20 in total

1.  KIAA0101 mRNA overexpression in peripheral blood mononuclear cells acts as predictive marker for hepatic cancer.

Authors:  Xiaomei Su; Tao Zhang; Peng Cheng; Yajie Zhu; Hua Li; Dong Li; Zhen Liu; Hui Gao; Zhenguo Zhao; Yu Zhao; Huanyi Liu
Journal:  Tumour Biol       Date:  2013-11-07

2.  NS5ATP9 mRNA levels in peripheral blood mononuclear cells predict prognosis in patients with gastric cancer.

Authors:  Dawei Yuan; Kun Zhu; Chengxue Dang; Yuewen Zheng; Rong Yan; Lei Shi; Kang Li
Journal:  Med Oncol       Date:  2014-07-05       Impact factor: 3.064

3.  [Screening of cell cycle-related genes regulated by KIAA0101 in gastric cancer].

Authors:  Zhi Wang; Chengxue Dang; Rong Yan; Hao Zhang; Dawei Yuan; Kang Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-09-30

4.  Circ_0005231 promotes the progression of esophageal squamous cell carcinoma via sponging miR-383-5p and regulating KIAA0101.

Authors:  Zhiguang Sun; Shaowei Zhang; Nan Zhang; Jianxin Wang; Jindong Wang; Junfeng Liu
Journal:  Thorac Cancer       Date:  2022-05-06       Impact factor: 3.223

5.  KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells.

Authors:  Hong Chen; Bairong Xia; Tianbo Liu; Mei Lin; Ge Lou
Journal:  Cancer Cell Int       Date:  2016-09-26       Impact factor: 5.722

6.  Paf15 expression correlates with rectal cancer prognosis, cell proliferation and radiation response.

Authors:  Rong Yan; Kun Zhu; Chengxue Dang; Ke Lan; Haonan Wang; Dawei Yuan; Wei Chen; Stephen J Meltzer; Kang Li
Journal:  Oncotarget       Date:  2016-06-21

7.  Variant 2 of KIAA0101, antagonizing its oncogenic variant 1, might be a potential therapeutic strategy in hepatocellular carcinoma.

Authors:  Lijuan Liu; Youyi Liu; Xiaobei Chen; Miao Wang; Yan Zhou; Ping Zhou; Wenxin Li; Fan Zhu
Journal:  Oncotarget       Date:  2017-07-04

8.  KIAA0101 is associated with human renal cell carcinoma proliferation and migration induced by erythropoietin.

Authors:  Shengjun Fan; Xin Li; Lu Tie; Yan Pan; Xuejun Li
Journal:  Oncotarget       Date:  2016-03-22

9.  Exploration of the diagnostic value and molecular mechanism of miR‑1 in prostate cancer: A study based on meta‑analyses and bioinformatics.

Authors:  Zu-Cheng Xie; Jia-Cheng Huang; Li-Jie Zhang; Bin-Liang Gan; Dong-Yue Wen; Gang Chen; Sheng-Hua Li; Hai-Biao Yan
Journal:  Mol Med Rep       Date:  2018-10-25       Impact factor: 2.952

10.  Literature optimized integration of gene expression for organ-specific evaluation of toxicogenomics datasets.

Authors:  Katerina Taškova; Jean-Fred Fontaine; Ralf Mrowka; Miguel A Andrade-Navarro
Journal:  PLoS One       Date:  2019-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.